News for 'Research Development and Standard'

'If I don't get it for 12th Fail, there will be another film...'

'If I don't get it for 12th Fail, there will be another film...'

Rediff.com27 Nov 2023

'There can be no bigger compliment than people walking away, carrying the film in their hearts, and thanking you for it.'

Israel-Hamas Conflict: India's IT Companies On Edge

Israel-Hamas Conflict: India's IT Companies On Edge

Rediff.com18 Oct 2023

'IT companies do not have a large presence there either in terms of market and team. So, the impact of the war will be minimal. But West Asia is an emerging economy.'

How monkeys were tracked for Covaxin trial

How monkeys were tracked for Covaxin trial

Rediff.com14 Nov 2021

The Rhesus macaque monkeys, used worldwide in medical research, are believed to be the best non-human primates for such studies.

India-China Tensions Move To Global Arena

India-China Tensions Move To Global Arena

Rediff.com23 Aug 2023

'The future of BRICS is under stress as Chinese attempts to expand the platform are being resisted by India and Brazil.' 'Beijing is focused on a quick expansion with the aim of giving the platform a distinctly anti-Western orientation, which New Delhi and Brasilia seem to have no interest in,' notes Harsh V Pant.

Nations must ensure cryptocurrency does not end in wrong hands: PM

Nations must ensure cryptocurrency does not end in wrong hands: PM

Rediff.com18 Nov 2021

Modi cautioning that cryptocurrency can spoil the youth.

'AI is going to be used as a weapon by the bad guys'

'AI is going to be used as a weapon by the bad guys'

Rediff.com17 Oct 2022

'This is a race where every technology can be used by the bad guys and good guys.'

Markets end on mixed note; Sensex climbs 158 points, Nifty dips

Markets end on mixed note; Sensex climbs 158 points, Nifty dips

Rediff.com1 Feb 2023

Equity benchmarks Sensex and Nifty ended on a mixed note on Wednesday as the euphoria about the Budget fizzled out, with investors going for profit-taking ahead of the Fed interest rate decision. The 30-share BSE benchmark Sensex climbed 158.18 points or 0.27 per cent to settle at 59,708.08 after it trimmed most of the intra-day gains. During the day, it had zoomed 1,223.54 points or 2 per cent to 60,773.44.

Joshimath Tourism Industry Stares At Sinking Fortunes

Joshimath Tourism Industry Stares At Sinking Fortunes

Rediff.com11 Jan 2023

The tourism industry plays a vital role in the town, accounting for 70 per cent of its economy, according to experts.

Will 2023 Be A Repeat Of 2015?

Will 2023 Be A Repeat Of 2015?

Rediff.com5 Jun 2023

States have been told to prepare in advance to counter any impact of an adverse southwest monsoon.

Why Mumbaikars Are Wheezing And Coughing

Why Mumbaikars Are Wheezing And Coughing

Rediff.com29 Mar 2023

La Nina, construction worsen air quality; spike in respiratory ailments.

Key mantra for India's pharma sector in 2023

Key mantra for India's pharma sector in 2023

Rediff.com21 Dec 2022

Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of inflation and pricing pressures in the global markets. While R&D investment, market competitiveness, regulatory scrutiny, and domestic price regulations are expected to shape the growth of generics and injectable products, concerns such as price control and customs duties on medical equipment will continue to bother the healthcare industry in 2023. The industry believes that in view of India's G20 Presidency, digital health innovation, achieving universal health coverage, improving healthcare infrastructure and delivery will continue to be the key driving factors in 2023.

'$33 billion was taken out of India -- the highest-ever'

'$33 billion was taken out of India -- the highest-ever'

Rediff.com6 Dec 2022

'Yet the market didn't do all that badly because it was cushioned by domestic inflows.'

Yoginder Alagh's Death Is A Loss To India

Yoginder Alagh's Death Is A Loss To India

Rediff.com7 Dec 2022

For Yoginder, it is a release from pain. But for us, his friends, it is the loss of a warm and generous life companion, says Nitin Desai of his 50-year association with the eminent economist who passed into the ages on December 6, 2022.

8 vaccines, 4 treatments in India's COVID-19 arsenal

8 vaccines, 4 treatments in India's COVID-19 arsenal

Rediff.com28 Dec 2021

The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments available in India to 12.

UK signs deal for 90 million COVID-19 vaccine doses

UK signs deal for 90 million COVID-19 vaccine doses

Rediff.com20 Jul 2020

To enable large-scale vaccine studies to take place across the UK, the aim is to get 500,000 people signed up by October, which is considered vital in the fight against coronavirus.

'Omission Of Darwin's Theory of Evolution Is A Serious Error Of Judgment'

'Omission Of Darwin's Theory of Evolution Is A Serious Error Of Judgment'

Rediff.com28 Apr 2023

'We will bring up students with an imperfect understanding of their own history and a superficial understanding of science.' 'This is not what we should be doing to future generations.'

Bharat Biotech's Covaxin vaccine cleared by special panel

Bharat Biotech's Covaxin vaccine cleared by special panel

Rediff.com2 Jan 2021

Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research.

Boom Motors recalls Corbett ebikes, halts production after fatal accident

Boom Motors recalls Corbett ebikes, halts production after fatal accident

Rediff.com30 Apr 2022

So far at least eight incidents of EV fires have been reported in just over a month's time.

Big Tech Is Rushing To Train AI In Local Languages

Big Tech Is Rushing To Train AI In Local Languages

Rediff.com21 Feb 2023

Indian mobile and Web consumers speak in 30 languages and around 1,600 dialects.

iPhone 14 production cut may not impact Apple's India plans: Experts

iPhone 14 production cut may not impact Apple's India plans: Experts

Rediff.com8 Oct 2022

The Apple iPhone comprises 44 per cent of the global smartphone market's revenues and it is the second most-such device to be shipped after Samsung. More than half of smartphones used in the US are iPhones. More than 7 million iPhones are expected to be sold in India in 2022, extending the user base to 20 million, according to market research and analyst firm Techarc. Hence, the news about Apple scaling down its production target for iPhone 14 in India has made news.

Stop advertising Covid 'medicines', give details: Govt to Patanjali

Stop advertising Covid 'medicines', give details: Govt to Patanjali

Rediff.com24 Jun 2020

Ramdev's herbal medicine company Patanjali Ayurved has launched 'Coronil tablet and Swasari vati' medicines claiming they can cure the highly contagious disease within seven days.

Modi, WHO chief lay the ground for traditional medicine centre in Jamnagar

Modi, WHO chief lay the ground for traditional medicine centre in Jamnagar

Rediff.com19 Apr 2022

Prime Minister Narendra Modi on Tuesday said the establishment of the WHO Global Centre for Traditional Medicine (WHO GCTM) in Jamnagar will usher in a new era of traditional medicine globally.

Air pollution reducing life expectancy in India by 5 years

Air pollution reducing life expectancy in India by 5 years

Rediff.com14 Jun 2022

The residents of Delhi stand to lose 10 years of life expectancy if the current air pollution level persists.

'The group has quality physical assets'

'The group has quality physical assets'

Rediff.com15 Jun 2023

'If there is any reason to change my holding in Adani group stocks, the Hindenburg report on the group is not the one.'

Will sub-par monsoon dent market sentiment?

Will sub-par monsoon dent market sentiment?

Rediff.com22 Apr 2023

While weather forecasters remain divided on how the monsoons will play out in India over the next few months, analysts believe the news at the current juncture - at best - can trigger a knee-jerk reaction in the markets. They believe it is too early to say whether the sub-par monsoon on account of El Nino can seriously dent the market sentiment in the short-to-medium term. "These are just initial forecasts and we will have another round / status update from the weather forecasters a month down the line.

How India can NEUTRALISE Enemy Drones

How India can NEUTRALISE Enemy Drones

Rediff.com23 Jul 2021

'An armed helicopter equipped with counter-drone systems will provide the airborne counter-drone capability and flexibility needed to protect India's critical assets.'

TCS, HZL, CIL boost India Inc's dividend payout to record Rs 2.3 trillion

TCS, HZL, CIL boost India Inc's dividend payout to record Rs 2.3 trillion

Rediff.com18 May 2023

Corporate India continues to be generous in rewarding its shareholders with big dividend payouts. This is especially true for shareholders of companies such as Tata Consultancy Services (TCS), Hindustan Zinc (HZL), and Coal India (CIL) which are seen as cash cows of large business groups and the government. Boosted by a big payout by these three companies, the combined equity dividend payout by listed companies was up 38 per cent year-on-year (YoY) to a record high of Rs 2.27 trillion in 2022-23 (FY23), compared with Rs 1.65 trillion in 2021-22 (FY22).

Negligence Of Cybersecurity May Spoil The Party

Negligence Of Cybersecurity May Spoil The Party

Rediff.com28 Feb 2023

'As long as businesses do not consider cyber recovery an integral part of their enterprise IT, they remain greatly vulnerable.'

'I told them India was like a giant jumbo jet. It would take off slowly and be unstoppable'

'I told them India was like a giant jumbo jet. It would take off slowly and be unstoppable'

Rediff.com10 Jan 2023

This doctor couple put their faith in India. And in return India has put faith in them.

Is It Time To Invest In Silver?

Is It Time To Invest In Silver?

Rediff.com17 May 2023

The rally in silver may continue if the global economic recovery remains on course.

Is The Congress Doomed?

Is The Congress Doomed?

Rediff.com7 Dec 2023

The Congress needs to reorganise itself at the grassroots, infuse younger blood, and have more boots on the ground. Just offering freebies is not the answer anymore. Leadership matters, asserts Ramesh Menon.

India saw 23.5 lakh pollution deaths in 2019, highest in world

India saw 23.5 lakh pollution deaths in 2019, highest in world

Rediff.com18 May 2022

In India, air pollution is most severe in the Indo-Gangetic Plain (northern India), where topography and meteorology concentrate pollution from energy, mobility, industry, agriculture, and other activities, the researchers said.

Cyclone Biparjoy may prove to be killjoy for onset of monsoon

Cyclone Biparjoy may prove to be killjoy for onset of monsoon

Rediff.com7 Jun 2023

Cyclone 'Biparjoy', the first storm brewing in the Arabian Sea this year, has rapidly intensified into a severe cyclonic storm, with meteorologists predicting a 'mild' monsoon onset over Kerala and 'weak' progress beyond southern peninsular under its influence.

Why Is It An Attack On India?

Why Is It An Attack On India?

Rediff.com7 Feb 2023

India's Right-wing has sought to own our democracy by making itself appear the stuff of majority, and sometimes, a national ethos older than the Constitution on which our democracy is based, argues Shyam G Menon.

'No shell company in Mauritius; Hindenburg allegations false, baseless'

'No shell company in Mauritius; Hindenburg allegations false, baseless'

Rediff.com10 May 2023

In a boost to the embattled Adani Group, Mauritian Financial Services Minister Mahen Kumar Seeruttun has told the nation's Parliament that Hindenburg Research's allegations of the presence of 'shell' companies in the Island nation are 'false and baseless' and that Mauritius was in compliance with OECD-mandated tax rules. US short seller Hindenburg on January 24 alleged that billionaire Gautam Adani used shell companies based in Mauritius to manipulate stock prices of his Indian-listed companies.

BEWARE! Fraud Journals On The Rise

BEWARE! Fraud Journals On The Rise

Rediff.com27 Nov 2021

Cloned journals have become more rampant in the post-pandemic world.

How IITs are gearing up to fight COVID-19 menace

How IITs are gearing up to fight COVID-19 menace

Rediff.com31 Mar 2020

While some researchers are developing prototypes for ventilators to overcome their shortage, others have teamed up to develop testing kits.

Cyclone Yaas: DRDO to protect missile testing facilities

Cyclone Yaas: DRDO to protect missile testing facilities

Rediff.com25 May 2021

The Integrated Test Range of Defence Research and Development Organisation (DRDO) has taken various measures to protect its facilities at Chandipur and Abdul Kalam Island in Odisha, which are likely to be affected by cyclone 'Yaas', an official said.

New low-cost test can diagnose COVID-19 in just 20 minutes

New low-cost test can diagnose COVID-19 in just 20 minutes

Rediff.com14 Aug 2020

The rapid molecular test is highly accurate and easy to use, making it a prime candidate for use in settings with limited testing capabilities, according to the researchers.

IRCTC moves to monetise passenger data

IRCTC moves to monetise passenger data

Rediff.com26 Aug 2022

In a first of its kind move, the Indian Railways Catering and Tourism Corporation (IRCTC), the ticket booking arm of the Indian Railways, is looking to monetise its bank of passenger data while conducting business with private and government companies. IRCTC has a large bank of data related to every online railway ticket ever generated as it is the country's only railway ticketing platform, an IRCTC official told Business Standard. The public sector undertaking, which has sought the services of a consultant to assist with the monetisation process, plans to raise Rs 1,000 crore through this exercise.